Topical dexamethasone–cyclodextrin nanoparticle eye drops for non‐infectious Uveitic macular oedema and vitritis – a pilot study
Shiri Shulman(Tel Aviv University), Zohar Habot‐Wilner(Tel Aviv University), Einar Stefánsson(University of Iceland), Amir Rosenblatt(Tel Aviv University), Gauti Jóhannesson(University of Iceland), Anat Loewenstein(Tel Aviv University)
Cited by 45
Related Papers
Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
|Redox Biology|2021|227
Retinal Oxygenation and Laser Treatment in Patients With Diabetic Retinopathy
|American Journal of Ophthalmology|1992|151
Normal-Tension Glaucoma Has Normal Intracranial Pressure
|Ophthalmology|2017|97
Topical dexamethasone <i>γ</i>‐cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema
|Acta Ophthalmologica|2015|96
The pressure difference between eye and brain changes with posture
|Annals of Neurology|2016|88